US2008234470A1PendingUtilityA1
Kcnb: a novel potassium channel protein
Est. expiryMar 3, 2020(expired)· nominal 20-yr term from priority
A61P 9/06A61P 3/10A61P 9/04A61P 35/00A61P 9/00A61P 43/00A61P 25/24A61P 25/18A61P 25/00A61P 25/06A61P 25/08A61P 25/28A61P 25/16C07K 14/705A61P 1/18A61K 38/00
50
PatentIndex Score
0
Cited by
0
References
0
Claims
Abstract
The present invention provides nucleic acid and protein sequences for a novel potassium channel protein, KCNB. The herein-disclosed sequences can be used for any of a number of purposes, including for the specific detection of KCNB, for the identification of molecules that associate with and/or modulate the activity of KCNB, to diagnose any of a number of conditions associated with KCNB or KCNB activity, or to modulate the number or activity of KCNB molecules in a mammal.
Claims
exact text as granted — not AI-modified1 - 18 . (canceled)
19 . An antibody that selectively binds to a polypeptide comprising greater than 70% amino acid sequence identity to an amino acid sequence of SEQ ID NO: 1, or to a polypeptide comprising at least 30 contiguous amino acids of the amino acid sequence of SEQ ID NO: 1.
20 - 67 . (canceled)
68 . An antibody of claim 19 that selectively binds to a polypeptide comprising greater than 90% amino acid sequence identity to an amino acid sequence of SEQ ID NO: 1.
69 . An antibody of claim 19 that selectively binds to a polypeptide comprising greater than 95% amino acid sequence identity to an amino acid sequence of SEQ ID NO: 1.
70 . An antibody of claim 19 that selectively binds to a polypeptide having the amino acid sequence of SEQ ID NO. 1
71 . An antibody of claim 19 that selectively binds to a polypeptide comprising a fragment of the amino acid sequence of SEQ ID NO: 1, wherein the fragment is selected from the group consisting of the C-terminal domain, the M3 domain and the amino acid sequence from amino acid 30 to amino acid 70 of SEQ ID NO:1.Join the waitlist — get patent alerts
Track US2008234470A1 — get alerts on status changes and closely related new filings.
We store only your email — no account needed. See our privacy policy.